Alto Neuroscience Inc. (ANRO)
PHARMACEUTICAL PREPARATIONS
Alto Neuroscience Inc. (ANRO) is listed on the New York Stock Exchange, where it has traded since February 2, 2024.
- Listed On
- the New York Stock Exchange
- Listed Since
- February 2, 2024
- Employees
- 68
- Market Cap
- $1.0B
About Alto Neuroscience Inc.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 110 institutions reported holding ANRO, with 29.5 million shares worth $777.6 million in aggregate. The largest reported holder was Alpha Wave Global, with 3.7 million shares worth $97.8 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Alpha Wave Global | 3,707,757 | $98M | Unchanged |
| Commodore Capital | 2,723,196 | $72M | Unchanged |
| BlackRock | 2,121,009 | $56M | Added 218.38% |
| Vanguard | 1,805,142 | $48M | Added 29.07% |
| Perceptive Advisors | 1,609,893 | $42M | Reduced 19.9% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ANRO?
Alto Neuroscience Inc. (ANRO) is listed on the New York Stock Exchange, where it has traded since February 2, 2024.
Who are the largest institutional holders of ANRO?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ANRO were Alpha Wave Global, Commodore Capital and BlackRock.
How many institutions own ANRO?
110 institutions reported a position in ANRO for the quarter ended June 30, 2026, worth $777.6 million in total.
Did institutions buy or sell ANRO last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for ANRO.
Every reported institutional holder, plus insider and congressional trades in ANRO, on SentiSense.